Pasar al contenido principal

NUEVOS FARMACOS EN BIOLOGIA DE CROMOSOMAS. DISEÑO DE INHIBIDORES ESPECIFICOS DEL COMPLEJO DE COHESINAS.

RTI2018-094434-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

More than one HMG-CoA lyase: the classical mitochondrial enzyme plus the peroxisomal and the cytosolic ones

  • Arnedo, María
  • Latorre-Pellicer, Ana
  • Lucia-Campos, Cristina
  • Gil-Salvador, Marta
  • Antoñanzas-Peréz, Rebeca
  • Gómez-Puertas, Paulino
  • Bueno-Lozano, Gloria
  • Puisac, Beatriz
  • Pié, Juan
There are three human enzymes with HMG-CoA lyase activity that are able to synthesize ketone bodies in different subcellular compartments. The mitochondrial HMG-CoA lyase was the first to be described, and catalyzes the cleavage of 3-hydroxy-3-methylglutaryl CoA to acetoacetate and acetyl-CoA, the common final step in ketogenesis and leucine catabolism. This protein is mainly expressed in the liver and its function is metabolic, since it produces ketone bodies as energetic fuels when glucose levels are low. Another isoform is encoded by the same gene for the mitochondrial HMG-CoA lyase (HMGCL), but it is located in peroxisomes. The last HMG-CoA lyase to be described is encoded by a different gene, HMGCLL1, and is located in the cytosolic side of the endoplasmic reticulum membrane. Some activity assays and tissue distribution of this enzyme have shown the brain and lung as key tissues for studying its function. Although the roles of the peroxisomal and cytosolic HMG-CoA lyases remain unknown, recent studies highlight the role of ketone bodies in metabolic remodeling, homeostasis, and signaling, providing new insights into the molecular and cellular function of these enzymes., This work was supported by: Diputación General de Aragón-FEDER: European Social Fund (Grupo de Referencia B32_17R, to Juan Pié.), as well as grants from the Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación RTC-2017-6494-1 and RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE) to Paulino Gómez-Puertas. Beatriz Puisac and Juan Pié are members of CIBERER-GCV02 and María Arnedo, Ana Latorre-Pellicer, Cristina Lucia-Campos, Marta Gil-Salvador, Rebeca Antoñanzas-Peréz, Beatriz Puisac and Juan Pié are members of ISS-Aragon at the School of Medicine, University of Zaragoza., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular characterization of Tc964, a novel antigenic protein from trypanosoma cruzi

  • Ruiz-Márvez, Elizabeth
  • Ramírez, César Augusto
  • Rodríguez, Eliana Rocío
  • Flórez, Magda Mellisa
  • Delgado, Gabriela
  • Guzmán, Fanny
  • Gómez-Puertas, Paulino
  • Requena, José María
  • Puerta, Concepción J.
The Tc964 protein was initially identified by its presence in the interactome associated with the LYT1 mRNAs, which code for a virulence factor of Trypanosoma cruzi. Tc964 is annotated in the T. cruzi genome as a hypothetical protein. According to phylogenetic analysis, the protein is conserved in the different genera of the Trypanosomatidae family; however, recognizable orthologues were not identified in other groups of organisms. Therefore, as a first step, an in-depth molecular characterization of the Tc946 protein was carried out. Based on structural predictions and molecular dynamics studies, the Tc964 protein would belong to a particular class of GTPases. Subcellular fractionation analysis indicated that Tc964 is a nucleocytoplasmic protein. Additionally, the protein was expressed as a recombinant protein in order to analyze its antigenicity with sera from Chagas disease (CD) patients. Tc964 was found to be antigenic, and B-cell epitopes were mapped by the use of synthetic peptides. In parallel, the Leishmania major homologue (Lm964) was also expressed as recombinant protein and used for a preliminary evaluation of antigen cross-reactivity in CD patients. Interestingly, Tc964 was recognized by sera from Chronic CD (CCD) patients at different stages of disease severity, but no reactivity against this protein was observed when sera from Colombian patients with cutaneous leishmaniasis were analyzed. Therefore, Tc964 would be adequate for CD diagnosis in areas where both infections (CD and leishmaniasis) coexist, even though additional assays using larger collections of sera are needed in order to confirm its usefulness for differential serodiagnosis., This research was funded by Ministerio de Ciencia, Tecnología e Innovación (Minciencias) and Pontificia Universidad Javeriana, research project ID PPTA 120356933228 granted to C.J.P. The article publication was funded by the Vicerrectoría de Investigación from the Pontificia Universidad Javeriana, code 120813F0401200. The Network of Tropical Diseases Research RICET (RD16/0027/0008, Instituto de Salud Carlos III and co-funded by FEDER) to J.M.R., and grants from the Spanish Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación RTC-2017-6494-1 and RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE) to P.G.-P., E.R.-M and E.R.R. were supported by Minciencias convocatoria doctorados nacionales 647-2014 and convocatoria jóvenes investigadores e innovadores 706-2015, respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel dominant KCNQ2 exon 7 partial in-frame duplication in a complex epileptic and neurodevelopmental delay syndrome

  • Lazo, Pedro A.
  • García, Juan L.
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
  • Arjona, César
  • Villarroel, Álvaro
  • González-Sarmiento, Rogelio
  • Fons, Carmen
Complex neurodevelopmental syndromes frequently have an unknown etiology, in which genetic factors play a pathogenic role. This study utilizes whole-exome sequencing (WES) to examine four members of a family with a son presenting, since birth, with epileptic-like crises, combined with cerebral palsy, severe neuromotor and developmental delay, dystonic tetraparexia, axonal motor affectation, and hyper-excitability of unknown origin. The WES study detected within the patient a de novo heterozygous in-frame duplication of thirty-six nucleotides within exon 7 of the human KCNQ2 gene. This insertion duplicates the first twelve amino acids of the calmodulin binding site I. Molecular dynamics simulations of this KCNQ2 peptide duplication, modelled on the 3D structure of the KCNQ2 protein, suggest that the duplication may lead to the dysregulation of calcium inhibition of this protein function., Grants from Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León (CLC-2017-01 and UIC-258) to P.A.L. Ministerio de Economía, Industria y Competitividad (CTQ2015-68756-R, BFU2015-66910-R) to A.V. Ministerio de Economía y Competitividad-Fondo Social Europeo Grant from Instituto de Salud Carlos III-Fondo Social Europeo (PI16/01920) to R. G-S. Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (RTC-2017-6494-1 and RTI2018-094434-B-I00) to P. G-P. Financial support of the Departament de Salut de la Generalitat de Catalunya-URDCat Project (SLT002/16/00174) to C.A. and C.F., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathy

  • Marcos, Ana T.
  • Martín-Doncel, Elena
  • Morejón-García, Patricia
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Segura‐Puimedon, María
  • Armengol, Lluís
  • Navarro‐Pando, José M.
  • Lazo, Pedro A.
[Background]: Distal motor neuropathies with a genetic origin have a heterogeneous clinical presentation with overlapping features affecting distal nerves and including spinal muscular atrophies and amyotrophic lateral sclerosis. This indicates that their genetic background is heterogeneous., [Patient and methods]: In this work, we have identified and characterized the genetic and molecular base of a patient with a distal sensorimotor neuropathy of unknown origin. For this study, we performed whole‐exome sequencing, molecular modelling, cloning and expression of mutant gene, and biochemical and cell biology analysis of the mutant protein., [Results]: A novel homozygous recessive mutation in the human VRK1 gene, coding for a chromatin kinase, causing a substitution (c.637T > C; p.Tyr213His) in exon 8, was detected in a patient presenting since childhood a progressive distal sensorimotor neuropathy and spinal muscular atrophy syndrome, with normal intellectual development. Molecular modelling predicted this mutant VRK1 has altered the kinase activation loop by disrupting its interaction with the C‐terminal regulatory region. The p.Y213H mutant protein has a reduced kinase activity with different substrates, including histones H3 and H2AX, proteins involved in DNA damage responses, such as p53 and 53BP1, and coilin, the scaffold for Cajal bodies. The mutant VRK1(Y213H) protein is unable to rescue the formation of Cajal bodies assembled on coilin, in the absence of wild‐type VRK1., [Conclusion]: The VRK1(Y213H) mutant protein alters the activation loop, impairs the kinase activity of VRK1 causing a functional insufficiency that impairs the formation of Cajal bodies assembled on coilin, a protein that regulates SMN1 and Cajal body formation., E. M‐D., and P. M‐G. were supported by Junta de Castilla y León‐Fondo Social Europeo (ESF), and Ministerio de Educación‐FPU predoctoral (FPU16/01883) fellowships, respectively. This work was funded by grants from Ministerio de Ciencia, Innovación y Universidades‐Agencia Estatal de Investigación (SAF2016‐75744‐R, RED2018‐102801‐T) and Consejería de Educación‐Junta de Castilla y León‐ERDF (UIC‐258) to P.A.L. Ministerio de Ciencia, Innovación y Universidades‐Agencia Estatal de Investigación (RTC‐2017‐6494‐1 and RTI2018‐094434‐B‐I00) and European Commission project "CONNECT‐JPIAMR” Virtual Research Institute to P.G‐P. The Instituto de Biología Molecular y Celular del Cáncer is cofunded by Junta de Castilla y León‐European Regional Development Fund (CLC–2017–01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic convergence of CNVs in genes functionally associated to a severe neuromotor developmental delay syndrome

  • García-Hernández, Juan L.
  • Corchete, Luis A.
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Fons, Carmen
  • Lazo, Pedro A.
© The Author(s)., [Background]: Complex developmental encephalopathy syndromes might be the consequence of unknown genetic alterations that are likely to contribute to the full neurological phenotype as a consequence of pathogenic gene combinations. [Methods]: To identify the additional genetic contribution to the neurological phenotype, we studied as a test case a boy, with a KCNQ2 exon-7 partial duplication, by single-nucleotide polymorphism (SNP) microarray to detect copy-number variations (CNVs). [Results]: The proband presented a cerebral palsy like syndrome with a severe motor and developmental encephalopathy. The SNP array analysis detected in the proband several de novo CNVs, nine partial gene losses (LRRC55, PCDH9, NALCN, RYR3, ELAVL2, CDH13, ATP1A2, SLC17A5, ANO3), and two partial gene duplications (PCDH19, EFNA5). The biological functions of these genes are associated with ion channels such as calcium, chloride, sodium, and potassium with several membrane proteins implicated in neural cell-cell interactions, synaptic transmission, and axon guidance. Pathogenically, these functions can be associated to cerebral palsy, seizures, dystonia, epileptic crisis, and motor neuron dysfunction, all present in the patient. [Conclusions]: Severe motor and developmental encephalopathy syndromes of unknown origin can be the result of a phenotypic convergence by combination of several genetic alterations in genes whose physiological function contributes to the neurological pathogenic mechanism., Grants from Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León (CSI264P20, CLC-2017-01, and UIC-258) to P.A.L. Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (RTC-2017-6494-1 and RTI2018-094434-B-I00) to P. G-P. Departament de Salut de la Generalitat de Catalunya-URDCat Project (SLT002/16/00174) to C.F.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dysfunctional Homozygous VRK1-D263G Variant Impairs the Assembly of Cajal Bodies and DNA Damage Response in Hereditary Spastic Paraplegia

  • Morejón-García, Patricia
  • Keren, Boris
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Mochel, Fanny
  • Lazo, Pedro A.
[Background and Objectives]: To conduct a genetic and molecular functional study of a family with members affected of hereditary spastic paraplegia (HSP) of unknown origin and carrying a novel pathogenic vaccinia-related kinase 1 (VRK1) variant., [Methods]: Whole-exome sequencing was performed in 2 patients, and their parents diagnosed with HSP. The novel VRK1 variant was detected by whole-exome sequencing, molecularly modeled and biochemically characterized in kinase assays. Functionally, we studied the role of this VRK1 variant in DNA damage response and its effect on the assembly of Cajal bodies (CBs)., [Results]: We have identified a very rare homozygous variant VRK1-D263G with a neurologic phenotype associated with HSP and moderate intellectual disability. The molecular modeling of this VRK1 variant protein predicted an alteration in the folding of a loop that interferes with the access to the kinase catalytic site. The VRK1-D263G variant is kinase inactive and does not phosphorylate histones H2AX and H3, transcription factors activating transcription factor 2 and p53, coilin needed for assembly of CBs, and p53 binding protein 1, a DNA repair protein. Functionally, this VRK1 variant protein impairs CB formation and the DNA damage response., [Discussion]: This report expands the neurologic spectrum of neuromotor syndromes associated with a new and rare VRK1 variant, representing a novel pathogenic participant in complicated HSP and demonstrates that CBs and the DNA damage response are impaired in these patients., P. M-G. was supported by Ministerio de Educación-FPU predoctoral fellowship (FPU16/01883). This work was funded by grants from Agencia Estatal de Investigaci´on/ Ministerio de Ciencia e Innovaci´on (PID2019-105610RBI00) and Consejería de Educación-Junta de Castilla y León (CSI264P20) to P.A.L. Agencia Estatal de Investigaci´onMinisterio de Ciencia, Innovaci´on y Universidades (RTC2017-6494-1 and RTI2018-094434-B-I00) and European Commission project “CONNECT-JPIAMR Virtual Research Institute” to P.G-P. The Instituto de Biolog´ıa Molecular y Celular del Cancer is funded by a grant from Junta de Castilla y León-FEDER (CLC-2017-01).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

STAG2: Computational Analysis of Missense Variants Involved in Disease

  • Ros-Pardo, David
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
The human STAG2 protein is an essential component of the cohesin complex involved in cellular processes of gene expression, DNA repair, and genomic integrity. Somatic mutations in the STAG2 sequence have been associated with various types of cancer, while congenital variants have been linked to developmental disorders such as Mullegama–Klein–Martinez syndrome, X-linked holoprosencephaly-13, and Cornelia de Lange syndrome. In the cohesin complex, the direct interaction of STAG2 with DNA and with NIPBL, RAD21, and CTCF proteins has been described. The function of STAG2 within the complex is still unknown, but it is related to its DNA binding capacity and is modulated by its binding to the other three proteins. Every missense variant described for STAG2 is located in regions involved in one of these interactions. In the present work, we model the structure of 12 missense variants described for STAG2, as well as two other variants of NIPBl and two of RAD21 located at STAG2 interaction zone, and then analyze their behavior through molecular dynamic simulations, comparing them with the same simulation of the wild-type protein. This will allow the effects of variants to be rationalized at the atomic level and provide clues as to how STAG2 functions in the cohesin complex., This research was financed by the following grants: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MCIU-AEI, RTI2018-094434-B-I00 and PID2021-126625OB-I00/10.13039/501100011033/FEDER, EU), and Instituto de Salud Carlos III (DTS20-00024)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy

  • Campos Díaz, Aurora
  • Morejón-García, Patricia
  • Monte-Serrano, Eva
  • Ros-Pardo, David
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Lazo, Pedro A.
Rare recessive variants in the human VRK1 gene are associated with several motor neuron diseases (MND), such as amyotrophic lateral sclerosis, spinal muscular atrophy, or distal hereditary motor neuropathies (dHMN). A case with dHMN carrying two novel VRK1 gene variants, expressing Leu200Pro (L200P) and Arg387His (R387H) variant proteins, identified that these protein variants are functionally different. The Leu200Pro variant shares with several variants in the catalytic domain the loss of the kinase activity on different substrates, such as histones, p53, or coilin. However, the distal Arg387His variant and the distal Trp375* (W375X) chinese variant, both located at the end of the low complexity C-terminal region and proximal to the termination codon, retain their catalytic activity on some substrates, and mechanistically their functional impairment is different. The L200P variant, as well as most VRK1 pathogenic variants, impairs the phosphorylation of BAF and histone H4K16 acetylation, which are required for DNA attachment to the nuclear envelope and chromatin accessibility to DNA repair mechanisms, respectively. The R387H variant impairs phosphorylation of H2AX, an early step in different types of DNA damage responses. The functional variability of VRK1 protein variants and their different combinations are a likely contributor to the clinical phenotypic heterogeneity of motor neuron and neurological diseases associated with rare VRK1 pathogenic variants., Agencia Estatal de Investigación, PID2019-105610RB-I00, Pedro A. Lazo, PID2022-139598OB-I00, Pedro A. Lazo, RED2018-102801-T, Pedro A. Lazo, RTC-2017-6494-1, Paulino Gómez-Puertas, RTI2018-094434-B-I00, Paulino Gómez-Puertas, Consejería de Educación, Junta de Castilla y León, CSI264P20, Pedro A. Lazo,CLC-2017-01, Pedro A. Lazo, CSI004-18, Eva Monte-Serrano, European JPIAMR network “EPIC-Alliance, Ministerio de Universidades, FPU20/02978, Aurora Campos-Díaz, FPU16/01883, Patricia Morejón-García., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Novel Intragenic Duplication in the HDAC8 Gene Underlying a Case of Cornelia de Lange Syndrome

  • Lucia-Campos, Cristina
  • Valenzuela, Irene
  • Latorre-Pellicer, Ana
  • Ros-Pardo, David
  • Puisac, Beatriz
  • Castells, Neus
  • Gil-Salvador, Marta
  • Arnedo, María
  • Plaja, Alberto
  • Tenes, Anna
  • Cuscó, Ivon
  • Trujillano, Laura
  • Ramos, Feliciano J
  • Tizzano, Eduardo F
  • Gómez-Puertas, Paulino
  • Pié, Juan
Cornelia de Lange syndrome (CdLS) is a multisystemic genetic disorder characterized by distinctive facial features, growth retardation, and intellectual disability, as well as various systemic conditions. It is caused by genetic variants in genes related to the cohesin complex. Single-nucleotide variations are the best-known genetic cause of CdLS; however, copy number variants (CNVs) clearly underlie a substantial proportion of cases of the syndrome. The NIPBL gene was thought to be the locus within which clinically relevant CNVs contributed to CdLS. However, in the last few years, pathogenic CNVs have been identified in other genes such as HDAC8, RAD21, and SMC1A. Here, we studied an affected girl presenting with a classic CdLS phenotype heterozygous for a de novo ~32 kbp intragenic duplication affecting exon 10 of HDAC8. Molecular analyses revealed an alteration in the physiological splicing that included a 96 bp insertion between exons 9 and 10 of the main transcript of HDAC8. The aberrant transcript was predicted to generate a truncated protein whose accessibility to the active center was restricted, showing reduced ease of substrate entry into the mutated enzyme. Lastly, we conclude that the duplication is responsible for the patient’s phenotype, highlighting the contribution of CNVs as a molecular cause underlying CdLS., This work was supported by the Spanish Ministry of Health-ISCIII Fondo de Investigación Sanitaria (FIS) (Ref. PI19/01860, to F.J.R. and J.P.) and Diputación General de Aragón-FEDER: European Social Fund (Grupo de Referencia B32_17R/B32_20R, to J.P.). A.L.-P. is supported by a “Juan de la Cierva-Incorporación” postdoctoral grant from MICIU (Spanish Ministry of Science and Universities), M.G.-S. is supported by a Predoctoral Fellowship from the Diputación General de Aragón, and C.L.-C. is supported by a Predoctoral Fellowship from the MH-ISCIII. This work was also supported by Spanish government grants RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE) and DTS20-00024 (ISCIII) to P.G.-P., as well as funds from the European JPIAMR network “EPIC-Alliance” to P.G.-P. The computational support of the “Centro de Computación Científica CCC-UAM” is gratefully recognized. This work was also partially supported by Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias co-funded with ERDF funds, Grant No. FIS PI20/01767) to A.P. and by Spanish Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias co-funded with ERDF funds, Grant No. FIS PI18/000687 to E.F.T.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Diversity of mechanisms to control bacterial GTP homeostasis by the mutually exclusive binding of adenine and guanine nucleotides to IMP dehydrogenase

  • Fernandez-Justel, David
  • Marcos-Alcalde, Íñigo
  • Abascal, Federico
  • Vidaña, Nerea
  • Gómez-Puertas, Paulino
  • Jiménez, Alberto
  • Revuelta, José L.
  • Buey, Rubén M.
IMP dehydrogenase(IMPDH) is an essential enzyme that catalyzes the rate-limiting step in the guanine nucleotide pathway. In eukaryotic cells, GTP binding to the regulatory domain allosterically controls the activity of IMPDH by a mechanism that is fine-tuned by post-translational modifications and enzyme polymerization. Nonetheless, the mechanisms of regulation of IMPDH in bacterial cells remain unclear. Using biochemical, structural, and evolutionary analyses, we demonstrate that, in most bacterial phyla, (p)ppGpp compete with ATP to allosterically modulate IMPDH activity by binding to a, previously unrecognized, conserved high affinity pocket within the regulatory domain. This pocket was lost during the evolution of Proteobacteria, making their IMPDHs insensitive to these alarmones. Instead, most proteobacterial IMPDHs evolved to be directly modulated by the balance between ATP and GTP that compete for the same allosteric binding site. Altogether, we demonstrate that the activity of bacterial IMPDHs is allosterically modulated by a universally conserved nucleotide-controlled conformational switch that has divergently evolved to adapt to the specific particularities of each organism. These results reconcile the reported data on the crosstalk between (p)ppGpp signaling and the guanine nucleotide biosynthetic pathway and reinforce the essential role of IMPDH allosteric regulation on bacterial GTP homeostasis., Instituto de Salud Carlos III, Grant/Award Number: DTS20-00024; Ministerio de Ciencia e Innovación, Grant/Award Numbers: BIO2017-88435-R, PID2019-109671GB-I00, PID2020-118200RB-I00, RTC-2017-6494-1, RTI2018-094434-B-I00
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder

  • Christensen, Maria B.
  • Levy, Amanda M.
  • Mohammadi, Nazanin A.
  • Niceta, Marcello
  • Kaiyrzhanov, Rauan
  • Dentici, Maria Lisa
  • Al Alam, Chadi
  • Alesi, Viola
  • Benoit, Valérie
  • Bhatia, Kailash P.
  • Bierhals, Tatjana
  • Boßelmann, Christian M.
  • Buratti, Julien
  • Callewaert, Bert
  • Ceulemans, Berten
  • Charles, Perrine
  • De Wachter, Matthias
  • Dehghani, Mohammadreza
  • D'Haenens, Erika
  • Doco-Fenzy, Martine
  • Geßner, Michaela
  • Gobert, Cyrielle
  • Guliyeva, Ulviyya
  • Haack, Tobias B.
  • Hammer, Trine B.
  • Heinrich, Tilman
  • Hempel, Maja
  • Herget, Theresia
  • Hoffmann, Ute
  • Horvath, Judit
  • Houlden, Henry
  • Keren, Boris
  • Kresge, Christina
  • Kumps, Candy
  • Lederer, Damien
  • Lermine, Alban
  • Magrinelli, Francesca
  • Maroofian, Reza
  • Mehrjardi, Mohammad Yahya Vahidi
  • Moudi, Mahdiyeh
  • Müller, Amelie J.
  • Oostra, Anna J.
  • Pletcher, Beth A.
  • Ros-Pardo, David
  • Samarasekera, Shanika
  • Tartaglia, Marco
  • Van Schil, Kristof
  • Vogt, Julie
  • Wassmer, Evangeline
  • Winkelmann, Juliane
  • Zaki, Maha S.
  • Zech, Michael
  • Lerche, Holger
  • Radio, Francesca Clementina
  • Gómez-Puertas, Paulino
  • Møller, Rikke S.
  • Tümer, Zeynep
Biallelic variants of the gene encoding for the zinc-finger protein 142 (ZNF142) have recently been associated with intellectual disability (ID), speech impairment, seizures, and movement disorders in nine individuals from five families. In this study, we obtained phenotype and genotype information of 26 further individuals from 16 families. Among the 27 different ZNF142 variants identified in the total of 35 individuals only four were missense. Missense variants may give a milder phenotype by changing the local structure of ZF motifs as suggested by protein modeling; but this correlation should be validated in larger cohorts and pathogenicity of the missense variants should be investigated with functional studies. Clinical features of the 35 individuals suggest that biallelic ZNF142 variants lead to a syndromic neurodevelopmental disorder with mild to moderate ID, varying degrees of delay in language and gross motor development, early onset seizures, hypotonia, behavioral features, movement disorders, and facial dysmorphism. The differences in symptom frequencies observed in the unpublished individuals compared to those of published, and recognition of previously underemphasized facial features are likely to be due to the small sizes of the previous cohorts, which underlines the importance of larger cohorts for the phenotype descriptions of rare genetic disorders., BMBF (Treat-ION), Grant/Award Number: 01GM1907A; Deutsche Forschungsgemeinschaft, Grant/Award Number: 418081722 433158657; DFG FOR2715, Grant/Award Number: Le1030/16-2 Le1030/23-1; Edmond J. Safra Foundation; EU Horizon 2020; Italian Ministry of Health, Grant/Award Numbers: CCR-2017-23669081 RCR-2020-23670068_001 RCR2019-23669117_001, RF-2018-12366931; Medical Research Council, Grant/Award Number: MR/S01165X/1 MR/S005021/1 G0601943; Michael J. Fox Foundation; UCLH Biomedical Research Centre; Rosetrees Trust; SOLVE-RD; Spanish government grants RTC2017-6494, RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE), DTS20-00024 (ISCIII); the European JPIAMR network “EPIC-Alliance”; Wellcome Trust; Wellcome Trust (WT093205MA, WT104033AIA and the Synaptopathies Strategic Award, 165908)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In Silico Design of miniACE2 Decoys with In Vitro Enhanced Neutralization Activity against SARS-CoV-2, Encompassing Omicron Subvariants

  • Arévalo-Romero, Jenny Andrea
  • López-Cantillo, Gina
  • Moreno-Jiménez, Sara
  • Marcos-Alcalde, Íñigo
  • Ros-Pardo, David
  • Camacho, Bernardo Armando
  • Gómez-Puertas, Paulino
  • Ramírez-Segura, Cesar A.
The COVID-19 pandemic has overwhelmed healthcare systems and triggered global economic downturns. While vaccines have reduced the lethality rate of SARS-CoV-2 to 0.9% as of October 2024, the continuous evolution of variants remains a significant public health challenge. Next-generation medical therapies offer hope in addressing this threat, especially for immunocompromised individuals who experience prolonged infections and severe illnesses, contributing to viral evolution. These cases increase the risk of new variants emerging. This study explores miniACE2 decoys as a novel strategy to counteract SARS-CoV-2 variants. Using in silico design and molecular dynamics, blocking proteins (BPs) were developed with stronger binding affinity for the receptor-binding domain of multiple variants than naturally soluble human ACE2. The BPs were expressed in E. coli and tested in vitro, showing promising neutralizing effects. Notably, miniACE2 BP9 exhibited an average IC50 of 4.9 µg/mL across several variants, including the Wuhan strain, Mu, Omicron BA.1, and BA.2 This low IC50 demonstrates the potent neutralizing ability of BP9, indicating its efficacy at low concentrations.Based on these findings, BP9 has emerged as a promising therapeutic candidate for combating SARS-CoV-2 and its evolving variants, thereby positioning it as a potential emergency biopharmaceutical., This research was funded by Agencia Distrital de Educación Superior, Ciencia y Tecnología (ATENEA), Bogotá D.C., Colombia (Contract 057-2022, ID 9796). We also appreciate the fi-nancial support provided by the Pontificia Universidad Javeriana for J.A.A.-R. The P.G.-P. group (Í.M.-A. and D.R.-P.) at the CBM (CSIC-UAM) was supported by Spanish government grants RTI2018-094434-B-I00, PID2021-126625OB-I00 (MCIN/AEI-10.13039-501100011033-FEDER, EU.2022), and DTS20-00024 (ISCIII). We gratefully acknowledge the computational resources pro-vided by the Centro de Computación Científica (CCC-UAM). We also extend our sincere thanks to the National Health Institute of Colombia for their generous donation of the cPass kits., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

STAG2-RAD21 complex: A unidirectional DNA ratchet mechanism in loop extrusion

  • Ros-Pardo, David
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
This research was financed by the following grants: Ministerio de Ciencia, Innovación y Universidades, Agencia Estatal de Investigación (MCIU-AEI, RTI2018-094434-B-I00 and PID2021-126625OB-I00/10.13039/501100011033/FEDER, EU) and Instituto de Salud Carlos III (DTS20-00024).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The phenotypic and genotypic spectrum of individuals with mono- or biallelic ANK3 variants

  • Furia, Francesca
  • Levy, Amanda M.
  • Theunis, Miel
  • Bamshad, Michael J.
  • Bartos, Meghan N.
  • Bijlsma, Emilia K.
  • Brancati, Francesco
  • Cejudo, Lucile
  • Chong, Jessica X.
  • De Luca, Chiara
  • Dean, Sarah Joy
  • Egense, Alena
  • Goel, Himanshu
  • Guenzel, Adam J.
  • Hüffmeier, Ulrike
  • Legius, Eric
  • Mancini, Grazia M. S.
  • Marcos-Alcalde, Iñigo
  • Niclass, Tanguy
  • Planes, Marc
  • Redon, Sylvia
  • Ros-Pardo, David
  • Rouault, Karen
  • Schot, Rachel
  • Schuhmann, Sarah
  • Shen, Joseph J.
  • Tao, Alice M
  • Thiffault, Isabelle
  • Van Esch, Hilde
  • Wentzensen, Ingrid M.
  • Barakat, Tahsin Stefan
  • Møller, Rikke S.
  • Gómez-Puertas, Paulino
  • Chung, Wendy K.
  • Gardella, Elena
  • Tümer, Zeynep
NHGRI, Grant/Award Numbers: U01HG011744, U24 HG011746; Netherlands Organisation for Scientific Research, Grant/Award Number: 09150172110002; Italian Ministry of Health; Italian Ministry of University and Research, Grant/Award Numbers: PRIN2022, PRIN PNRR 2022; P50HD109879; Spanish Government, Grant/Award Numbers: RTI2018-094434-BI00, PID2021-126625OB-I00
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An engineered miniACE2 protein secreted by mesenchymal stromal cells effectively neutralizes multiple SARS-CoV- 2 variants in vitro

  • Moreno-Jiménez, Sara
  • López-Cantillo, Gina
  • Arevalo-Romero, Jenny Andrea
  • Perdomo-Arciniegas, Ana María
  • Moreno-Gonzalez, Andrea Marisol
  • Devia-Mejia, Bellaneth
  • Camacho, Bernardo Armando
  • Gómez-Puertas, Paulino
  • Ramirez-Segura, Cesar A.
SARS-CoV- 2 continues to evolve, producing novel Omicron subvariants through recombinant lineages that acquire new mutations, undermining existing antiviral strategies. The viral fitness and adaptive potential of SARS-CoV- 2 present significant challenges to emergency treatments, particularly monoclonal antibodies, which demonstrate reduced efficacy with the emergence of each new variant. Consequently, immunocompromised individuals, who are more susceptible to severe manifestations of COVID- 19 and face heightened risks of critical complications and mortality, remain vulnerable in the absence of effective emergency treatments. To develop translational approaches that can benefit this at-risk population and establish broader therapeutic strategies applicable across variants, we previously designed and engineered in silico miniACE2 decoys (designated BP2, BP9, and BP11). These decoys demonstrated promising efficacy in neutralizing Omicron subvariants. In this study, we leveraged the therapeutic potential of mesenchymal stromal cells (MSCs) for tissue repair and immunomodulation in lung injuries and used these cells as a platform for the secretion of BP2. Our innovative assays, which were conducted with the BP2 protein secreted into the culture supernatant of BP2-MSCs, demonstrated the potential for neutralizing SARS-CoV- 2, including Omicron subvariants. The development of these advanced therapeutic platforms holds significant promise for scalability to effectively mitigate the impact of severe COVID- 19, contributing to broader and more resilient treatment strategies against the evolving landscape of SARS-CoV- 2 variants., This research was financially supported by Agencia Distrital de Educación Superior, Ciencia y Tecnología (ATENEA), Bogotá D.C., Colombia (Contract 057 - 2022, ID 9796). The PGP group at the CBM (CSIC-UAM) was supported by Spanish Government grants RTI2018 - 094434-B-I00, PID2021 - 126625OB-I00 (MCIN/AEI- 10.13039 - 501100011033-FEDER, EU.2022 and DTS20 - 00024 (ISCIII) and gratefully recognizes the computational support of Centro de Computación Científica CCC-UAM. The authors gratefully acknowledge the funding support for C.A.R.-S. and G.L.-C. and S.M.-J. provided by Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud (IDCBIS), through resources transferred from Fondo Financiero Distrital de Salud (FFDS) to IDCBIS (Resolution 409, 2024, issued by the District Health Secretariat)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expanding the ABCA2-associated neurodevelopmental phenotype

  • Oja, Kaisa T.
  • Reinson, Karit
  • Ilisson, Mihkel
  • Örd, Daima
  • Wojcik, Monica H.
  • Seaby, Eleanor G.
  • Wittmann, Bryan M.
  • Kennedy, Adam D.
  • DeBalsi, Karen
  • Zweier, Christiane
  • Vasileiou, Georgia
  • Alkhawaja, Issam A.
  • Wirth, Thomas
  • Syrbe, Steffen
  • Platzer, Konrad
  • Alyamani, Suad
  • Alkuraya, Fowzan S.
  • Ros-Pardo, David
  • Marcos-Alcalde, Iñigo
  • Gómez-Puertas, Paulino
  • Vidailhet, Marie
  • Su, Ke
  • Fan, Shaohua
  • Ma, Yu
  • Wang, Yi
  • Renieri, Alessandra
  • Pinto, Anna Maria
  • Almadhoun, Farah
  • Petersen, Andrea K.
  • Magnussen, Kari
  • Bodamer, Olaf
  • Alanzi, Talal
  • Mohamed, Sarar
  • Alrabee, Hadeel
  • Alhaddad, Bader
  • Bakur, Khadijah
  • Fleischer, Nicole
  • Begtrup, Amber
  • Örd, Tõnis
  • Pajusalu, Sander
  • Õunap, Katrin
The ATP-binding cassette subfamily A member 2 ( ABCA2 ) gene encodes an ABC transporter protein. Bi-allelic loss-of-function variants in ABCA2 have been associated with an intellectual disability disorder. We aimed to delineate the phenotypic spectrum of individuals with monoallelic (MV) or bi-allelic (BV) variants in the ABCA2 gene. We collected clinical data via questionnaires and literature review. The ABCA2 protein was constructed using homology modeling. Untargeted plasma metabolomics was performed at Metabolon. A docetaxel toxicity cell culture model system was used to study the effects of plasmid-encoded ABCA2 and four ABCA2 variants (p.Asp615Glu [c.1845C>A], p.Phe754Ser [c.2261T>C], p.Ile786del [c.2356_2358del], and p.Arg926Trp [c.2776C>T]) on cell viability. Seventeen individuals with seventeen candidate ABCA2 variants were identified (seven MVs and ten BVs). Protein modeling predicted a likely significant impact for eight of 13 assessed variants. In cell viability assays, enforced expression of wild-type ABCA2 reduced viability in docetaxel-exposed cells. In contrast, none of the four variants affected viability, suggesting a loss or a marked reduction in transporter function. Untargeted metabolomics of three samples from two individuals showed a trend toward lower levels of polyunsaturated acylcarnitines. This study describes 17 individuals with candidate variants in the ABCA2 gene. The cell viability assays revealed that four variants (p.Asp615Glu, p.Phe754Ser, p.Ile786del, and p.Arg926Trp) had an altered ability to function as a transporter compared to wild-type ABCA2. Further studies are needed to clarify the pathomechanism of ABCA2 and the clinical significance of the variants., This work is supported by Estonian Research Council grants PUT355, PRG471, PRG2040, PRG1475, and PSG774; the Broad Institute Center for Mendelian Genomics (UM1HG008900) is funded by the National Human Genome Research Institute (NHGRI) with supplemental funding provided by the National Heart, Lung, and Blood Institute and the National Eye Institute (sequencing and analysis), and NHGRI grants U01HG011755 and R01HG009141 (analysis). M.H.W. is supported by NIH/NICHD K23HD102589. This work was also supported by Spanish government grants RTI2018-094434-B-I00, PID2021-126625OB-I00 (MCIN/AEI/10.13039/501100011033/ FEDER,EU.2022), and DTS20-00024 (ISCIII) to P.G.-P., as well as funds from the European JPIAMR network “EPIC-Alliance” to P.G.-P. The computational support of the “Centro de Computación Científica CCC-UAM” is gratefully recognized. A.R. and A.M.P. received funding from GENERA FSC 2014–2020 - Genoma medicina personalizzata - POS-Ministero della Salute T3-AN-04 to A.R.; EU H2020-SC1-FA-DTS-2018–2020, International Consortium for Integrative Genomics Prediction - grant agreement no. 101016775 to A.R.; and ERDERA Diagnostic Research Workstream to A.R.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Novel Intragenic Duplication in the HDAC8 Gene Underlying a Case of Cornelia de Lange Syndrome

  • Lucia-Campos, Cristina
  • Valenzuela, Irene|||0000-0003-2350-6058
  • Latorre Pellicer, Ana|||0000-0002-4703-6620
  • Ros-Pardo, David
  • Gil-Salvador, Marta
  • Arnedo, María|||0000-0001-9962-2157
  • Puisac, Beatriz|||0000-0003-0170-7326
  • Castells Sarret, Neus
  • Plaja Rustein, Alberto|||0000-0002-2398-1134
  • Tenes, Anna
  • Cusco, Ivon|||0000-0003-2104-9332
  • Trujillano, Laura|||0000-0002-3028-6156
  • Ramos, Feliciano J.|||0000-0002-5732-2209
  • Tizzano, Eduardo F.|||0000-0002-7116-6310
  • Gómez-Puertas, Paulino|||0000-0003-3131-729X
  • Pié, Juan|||0000-0003-3203-6254
Cornelia de Lange syndrome (CdLS) is a multisystemic genetic disorder characterized by distinctive facial features, growth retardation, and intellectual disability, as well as various systemic conditions. It is caused by genetic variants in genes related to the cohesin complex. Single-nucleotide variations are the best-known genetic cause of CdLS; however, copy number variants (CNVs) clearly underlie a substantial proportion of cases of the syndrome. The NIPBL gene was thought to be the locus within which clinically relevant CNVs contributed to CdLS. However, in the last few years, pathogenic CNVs have been identified in other genes such as HDAC8, RAD21, and SMC1A. Here, we studied an affected girl presenting with a classic CdLS phenotype heterozygous for a de novo ~32 kbp intragenic duplication affecting exon 10 of HDAC8. Molecular analyses revealed an alteration in the physiological splicing that included a 96 bp insertion between exons 9 and 10 of the main transcript of HDAC8. The aberrant transcript was predicted to generate a truncated protein whose accessibility to the active center was restricted, showing reduced ease of substrate entry into the mutated enzyme. Lastly, we conclude that the duplication is responsible for the patient's phenotype, highlighting the contribution of CNVs as a molecular cause underlying CdLS.